UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000063639
Receipt number R000058317
Scientific Title Efficacy and safety of antihistamine-releasing contact lenses during the Japanese cedar pollen season
Date of disclosure of the study information 2026/11/16
Last modified on 2026/11/16 09:58:29

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Efficacy and safety of antihistamine-releasing contact lenses during the Japanese cedar pollen season

Acronym

Efficacy and safety of antihistamine-releasing contact lenses

Scientific Title

Efficacy and safety of antihistamine-releasing contact lenses during the Japanese cedar pollen season

Scientific Title:Acronym

Efficacy and safety of antihistamine-releasing contact lenses during the Japanese cedar pollen season

Region

Japan


Condition

Condition

Patients with cedar pollen in Japan.

Classification by specialty

Clinical immunology Ophthalmology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To examine the efficacy of antihistamine-releasing contact lenses (ACLs; lenses included etafilcon A ( 0.019 mg ketotifen) in the cedar pollen season in Japan.

Basic objectives2

Others

Basic objectives -Others

Questionnaire survey of antihistamine-releasing contact lenses (ACLs; lenses included etafilcon A ( 0.019 mg ketotifen) in the cedar pollen season in Japan.

Trial characteristics_1

Confirmatory

Trial characteristics_2

Explanatory

Developmental phase

Not applicable


Assessment

Primary outcomes

To examine the efficacy of antihistamine-releasing contact lenses (ACLs; lenses included etafilcon A ( 0.019 mg ketotifen) for the conjunctival injection in the cedar pollen season in Japan.

Key secondary outcomes

To examine the safety of antihistamine-releasing contact lenses (ACLs; lenses included etafilcon A ( 0.019 mg ketotifen) for the conjunctival injection and side effects in the cedar pollen season in Japan.


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Self control

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Device,equipment

Interventions/Control_1

Ketotifen-containing contact lenses

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

70 years-old >=

Gender

Male and Female

Key inclusion criteria

Allergic conjunctivitis patients who received a full explanation of the purpose, methods, expected effects, side effects, privacy protection, compensation, and remuneration of this study, and who voluntarily wished to participate, either themselves or through a representative.

Key exclusion criteria

Patients whom the research physician deemed unsuitable as subjects for this study.

Target sample size

25


Research contact person

Name of lead principal investigator

1st name Hiroshi
Middle name
Last name Fujishima

Organization

Tsurumi University

Division name

Ophthalmology

Zip code

230-8501

Address

2-1-3 Tsurumi, Tsurumiku, Yokohama-shi, Japan

TEL

0455808599

Email

fujishima117@gmail.com


Public contact

Name of contact person

1st name Hiroshi
Middle name
Last name fujishima

Organization

Tsurumi University

Division name

Ophtalmology

Zip code

230-8501

Address

2-1-3 Tsurumi, Tsurumi-ku, Yokohama-shi, Japan

TEL

0455808599

Homepage URL


Email

fujishima117@gmail.com


Sponsor or person

Institute

Tsurumi University

Institute

Department

Personal name

Hiroshi Fujishima


Funding Source

Organization

Tsurumi University

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Tsurumi University

Address

2-1-3 Tsurumi, Tsurum-ku, Yokohama-shi, Japan

Tel

0455808599

Email

fujishima117@gmail.com


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2026 Year 11 Month 16 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

20

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Main results already published

Date of protocol fixation

2024 Year 10 Month 30 Day

Date of IRB

2024 Year 10 Month 30 Day

Anticipated trial start date

2026 Year 11 Month 17 Day

Last follow-up date

2027 Year 03 Month 31 Day

Date of closure to data entry

2027 Year 03 Month 31 Day

Date trial data considered complete

2027 Year 03 Month 31 Day

Date analysis concluded

2027 Year 03 Month 31 Day


Other

Other related information



Management information

Registered date

2026 Year 11 Month 16 Day

Last modified on

2026 Year 11 Month 16 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000058317